dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.
vabysmo 6mg/0.05ml sol. for intravitreal inj. vial
فابيسمو 6 مجم/0.05 مل فيال
faricimab · 6mg/0.05ml
32727EGP
Available
Active ingredient
faricimab
Strength
6mg/0.05ml
Form
vial
Manufacturer
f.hoffman la roche
Route
injection

Uses

Used for neovascular age-related macular degeneration, diabetic macular edema, and macular edema following retinal vein occlusion.

Do not use if

Ocular or periocular infection, active intraocular inflammation, or hypersensitivity to the drug.

Side effects

May cause increased intraocular pressure, eye discomfort, conjunctival hemorrhage, endophthalmitis, retinal detachment, or hypersensitivity reactions.

Warnings

Patients should promptly report symptoms of infection, retinal detachment, or vision changes after intravitreal injection.

How it works

Bispecific monoclonal antibody that inhibits VEGF-A and Ang-2 pathways, reducing vascular leakage and abnormal blood vessel growth.

Storage

Store refrigerated at 2°C–8°C. Do not freeze or shake.